Application Nr Approved Date Route Status External Links
ANDA202456 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Monotherapy And Combination Therapy Pioglitazone Tablets, Usp Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus In Multiple Clinical Settings [See Clinical Studies ( 14 )] . Important Limitations Of Use Pioglitazone Hydrochloride Exerts Its Antihyperglycemic Effect Only In The Presence Of Endogenous Insulin. Pioglitazone Hydrochloride Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. Use Caution In Patients With Liver Disease [See Warnings And Precautions ( 5.3 )] . Pioglitazone Tablets, Usp Are A Thiazolidinedione And An Agonist For Peroxisome Proliferator- Activated Receptor (Ppar) Gamma Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus In Multiple Clinical Settings. ( 1 , 14 ) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pioglitazone Hydrochloride PIOGLITAZONE HYDROCHLORIDE ZINC968326

Comments